Skip to main content
    I

    Iovance Biotherapeutics Inc (IOVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.55
    -0.21 (-2.71%)

    Market Cap: $3.59B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Iovance Biotherapeutics Inc (IOVA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Iovance Biotherapeutics are Ionis Pharmaceuticals (IONS), Immunovant (IMVT) and Ideaya Biosciences (IDYA). By market cap, Iovance Biotherapeutics ranks 6th of the 13 companies on this page; Immunovant (IMVT) is the largest at $7.07B.

    Peer Comparison

    IOVA's revenue growth of 80.1% is above the peer median of 13.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Iovance Biotherapeutics (IOVA)$3.59BN/A9.1x-58.2%N/A80.1%0.00%
    Ionis Pharmaceuticals Inc (IONS)$4.84BN/A4.8x-56.9%-29.3%54.9%0.00%
    Immunovant Inc (IMVT)$7.07BN/AN/A0.0%N/A0.0%0.00%
    Ideaya Biosciences Inc (IDYA)$3.08BN/A85.5x0.0%N/A-95.1%0.00%
    Viridian Therapeutics Inc (VRDN)$3.51BN/A128.5x0.0%-41.8%-63.5%0.00%
    Xencor Inc (XNCR)$2.78BN/A13.5x-58.8%-17.3%454.9%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Vir Biotechnology Inc (VIR)$1.71BN/A5.4x-61.0%N/A19582.0%0.00%
    Immunitybio Inc (IBRX)$6.40BN/A30.3x0.0%-780.5%52.3%0.00%
    Enliven Therapeutics Inc. (ELVN)$3.59BN/AN/A0.0%N/A0.0%0.00%
    Vericel Corp Ord (VCEL)$2.91B89.8x9.1x10.3%N/A26.5%0.00%
    Vera Therapeutics Inc (VERA)$2.03BN/A189.3x0.0%-83.0%0.0%0.00%
    Viking Therapeutics Inc (VKTX)$3.73BN/AN/A0.0%-61.0%0.0%0.00%
    Peer median$3.45B178.2x13.5x0.0%-51.4%13.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Iovance Biotherapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Ionis Pharmaceuticals Inc (IONS)
    Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
    IONS competitors
    Immunovant Inc (IMVT)
    Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
    IMVT competitors
    Ideaya Biosciences Inc (IDYA)
    IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality...
    IDYA competitors
    Viridian Therapeutics Inc (VRDN)
    Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses.
    VRDN competitors
    Xencor Inc (XNCR)
    Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed...
    XNCR competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Vir Biotechnology Inc (VIR)
    Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.
    VIR competitors
    Immunitybio Inc (IBRX)
    ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose...
    IBRX competitors
    Enliven Therapeutics Inc. (ELVN)
    Enliven Therapeutics Inc. (Ticker: ELVN) is an innovative biotechnology company focused on transforming cancer therapies and addressing critical healthcare...
    ELVN competitors
    Vericel Corp Ord (VCEL)
    Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures...
    VCEL competitors
    Vera Therapeutics Inc (VERA)
    Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases...
    VERA competitors
    Viking Therapeutics Inc (VKTX)
    Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders.
    VKTX competitors

    Frequently Asked Questions About IOVA

    Who are Iovance Biotherapeutics' main competitors?

    The companies most similar to Iovance Biotherapeutics include Ionis Pharmaceuticals (IONS), Immunovant (IMVT), Ideaya Biosciences (IDYA), Viridian Therapeutics (VRDN) and Xencor (XNCR), listed from the closest match.

    Who is Iovance Biotherapeutics' biggest competitor?

    Immunovant (IMVT) is the largest of the similar companies at $7.07B; Ionis Pharmaceuticals (IONS) is the closest match by business profile, size, sector and industry.

    How does IOVA stock compare with its competitors?

    IOVA's P/S is 9.1x against a peer median of 13.5x; its net margin is -58.2% against a peer median of 0.0%.

    Which of Iovance Biotherapeutics' competitors pays a higher dividend?

    Iovance Biotherapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Iovance Biotherapeutics bigger than its competitors?

    No. Iovance Biotherapeutics is 6th by market cap among the 13 companies on this page; the largest is Immunovant (IMVT) at $7.07B.